All the melanocytes -- a mature melanin-forming cell -- in a single frog larva either converted to the cancer-like form or remained completely normal.

TOP INSIGHT
All the melanocytes -- a mature melanin-forming cell -- in a single frog larva either converted to the cancer-like form or remained completely normal.
"We wanted to see if we could break the concordance among cells, which would help us understand how cells make group decisions and determine complex body-wide outcomes," said Tufts University's Michael Levin, who is the paper's corresponding author.
The AI model ultimately predicted that a precise combination of three reagents -- altanserin, a 5HTR2 inhibitor; reserpine, a VMAT inhibitor, and VP16-XlCreb1, mRNA encoding constitutively active CREB -- would achieve that outcome.
The team used the AI-discovered model to run 576 virtual experiments. The last try gave one precise combination of three drugs predicting partial melanocyte conversion.
"Our system predicted a three-component treatment, which we had never have come up with on our own, that achieved the exact outcome we wanted, and which we had not seen before in years of diverse experiments," Levin added.
He said that the team now wanted to do something different -- cure a disease, control cell behaviour and regenerate tissue.
MEDINDIA




Email










